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IBDW2014-00142-F0065 Table I Association between pQCT muscle outcomes and fractures with adjustment for covarlates and the CaMos Frailty Index
(CFI). *In this model, CFI was examined as an interaction with each muscle measurement.
Odds Ratio (OR) (95%CI)
pQCT variables A) Base model B) age, BMI, aBMD C) B + Falls D) C + CFI*
Muscle density 1.34 (1.09, 1.65) 1.39 (1.09, 1.77) 1.40 (1.09, 1.78) 1.35 (1.05, 1.74)
Muscle area 1.04 (0.85, 1.26) 1.19 (0.94, 1.50) 1.19 (0.94, 1.50) 1.05 (0.82, 1.35)
Muscle mass 1.14 (0.93, 1.38) 1.31 (1.03, 1.65) 1.30 (1.03, 1.65) 1.16 (0.90, 1.48)
Abstracts 237after applying the anthropometric corrections, we can gain insight into the
relevance of such adjustments. Whereas 8/31 (26%) patients cross from the
non-critical to the critical region with WH corrections applied to sub-head
whole-body BMD, 6/31 (19%) cross the same boundary when WHF corrections
are applied. The numbers are similar for BMC, with 9/31 (29%) crossing the
critical boundary with WH or WHF corrections applied. The number of pa-
tients crossing from critical to non-critical is 23% for BMC with the WH
correction and 29% for BMC with the WHF correction applied. However,
when BMD is considered, that change in classification is smaller for the WH
correction (13%) but not for the WHF correction (19%). The patterns are
similar for the other body sites.
Conclusion: Anthropometric correction for the calculation of Z-scores ap-
pears to affect a considerable fraction of patients with PWS. This is due to
the large abnormality in body size, and DXA measurements, being projection
measurements, are affected by body size. However, fracture risk has not yet
been studied in connection with DXA parameters in individuals with PWS,
and the full implication of anthropometric corrections needs to be evaluated
pending such investigations.
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Muscle is the largest source for energy production and storage and is a
determinant of frailty. Muscle has been linked to bone strength and fractures
previously. It is unknown how muscle relates to fractures independently of
frailty.
Objectives: To determine how muscle associates with fragility fractures in
postmenopausal women in the context of frailty.
Methods: A subset of women 60-85 years old participating in the Canadian
Multicentre Osteoporosis Study (CaMOS) completed peripheral quantitative
computed tomography (pQCT) (20 mm/s, 38 kVp, 500 mm in-plane resolu-
tion) scans using XCT 2000 (Stratec Medizintechnik) at 66% of the tibial
length (at year 16). Muscle density, mass, and area were derived using man-
ufacturer’s software. Comorbidities, cognition, energy level, function and
mobility questions obtained at year 10 were used to compute the CaMOS
frailty index (CFI). Incident fractures from baseline to year 15 were derived
from the CaMOS database. A binary logistics regression analysis measured
odds ratios (OR) for fragility fractures per standard deviation difference in
each muscle measure, adjusting for age, body mass index (BMI), lowest areal
bone mineral density (aBMD) T-score of total hip or lumbar spine and having
fallen within the last 12 months. The interaction of muscle outcomes and CFI
was examined in a second model, exploring the effect of muscle on fractures
at different values of CFI.
Results: Women (NZ525, mean age: 71.4  6.4 years; BMI: 26.90  4.85 kg/
m2) with one or more fragility fractures since baseline had a lower muscle
density than those without (pZ0.004). Muscle density and mass but not mus-
cle area, were associated with increased odds for fractures independent of
age, BMI, aBMD and falls. Further adjustment for CFI abolished the relation-
ship between fractures and muscle mass but not muscle density (Table I). Aplot of ORs and confidence intervals against CFI revealed that the signifi-
cance of associations between muscle density and fractures were preserved
only for CFI values less than 0.13. Above this value, confidence intervals
overlapped 1.0 (Figure 1). For CFI  0.13, the association between CFI and
each of muscle density (pZ0.023) and mass were significant (p<0.001) but
weak (R2 < 0.03). For CFI values above 0.13, these relationships were not
present.
Conclusions: Muscle density and muscle mass are associated with a history
of fragility fractures independent of frailty for those who were less frail
(CFI  0.13). For those who are frailer, muscle density and muscle mass
did not associate with fractures.
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Objective: Sarcopenia is an age-related systemic syndrome characterized by
a progressive loss of skeletal muscle mass and muscle strength as well as a
poor physical performance. Previous studies also suggested that sarcopenia
might be associated with low bone mineral density (BMD). A good animal
model is needed to explore the mechanism of sarcopenia and its relationship
with low BMD.
Methods: Senescence-accelerated mouse P8 (SAMP8) was selected as the an-
imal model and the target muscle was gastrocnemius. Parameters were
investigated at 6, 7, 8, 9, 10-month old (6 mice per timepoint). Functional
outcomes were measured with ex vivo muscle functional test system
(800A, Aurora Scientific Inc). H&E staining was performed for fiber cross-
sectional area evaluation and ATPase staining for muscle fiber typing. BMD
of L5 was measured with viva CT. Data analysis was done with oneeway
ANOVA followed by Tukey post-hoc test with p<0.05 as significant
difference.
Results: The peak of muscle mass (MM) appeared in 7-month group and sig-
nificant decrease was observed in 10-month group (-12.41%, p<0.01).
Compared with 10-month group, the 8-month group showed the largest
specific twitch force (SF0, 11.54%, p<0.01) and muscle cross-sectional
area (MCSA, 6.4%), while the peak of specific tetanic force (SFt, 13.23%,
p<0.05) appeared in 7-month group with the largest fatigue rate (34.5%,
p<0.05). Though there was no significant change in muscle stiffness and
muscle contractility in 8-month, it was still better than 10-month with a
higher contraction speed (35.1%, p<0.05). Animals in month 8 showed
the largest fiber cross-sectional area of type IIA (12.1%,p<0.05). Mean-
while, type IIB and type I showed a decreasing trend from 6-month to
10-month. From 6-month, BMD of L5 showed a continuous decreasing trend
(-10.39%).
Conclusion: Sarcopenia is defined by the decline of muscle mass and muscle
strength and is divided into pre-sarcopenia, sarcopenia and severe sarcope-
nia stages by the onset of decreased muscle mass, muscle strength and qual-
ity of life. Based on this criteria, our result suggested that sarcopeina started
between 7 and 8-month in SAMP8 animals and the 8-month animals were at
pre-sarcopenia stage and 10-month animals were at sarcopenia stage. The
result also indicated that the bone loss occurred earlier than the reduction
of skeletal muscle mass and muscle strength.
